Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequential FDG-PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago-Gastric Cancer

NCT07791329 is registered in ClinicalTrials.gov with Masaryk Memorial Cancer Institute as lead sponsor.

NCT NCT07791329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07791329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequential FDG-PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago-Gastric Cancer
Lead sponsor
Masaryk Memorial Cancer Institute
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2018
Completion date
November 30, 2024
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma - gastroesophageal junction (gej), gastric adenocarcinoma, gastroesophageal junction (gej) adenocarcinoma